Drug intelligence / Profile preview

Scarboost

Development stage: Unknown
Lead developer: Peaches Biotech
Modality: Stem Cell Therapies → Cell Therapies
Administration: Topical

Overview

**Scarboost** is an investigational regenerative-medicine program from Peaches Biotech for treatment of surgical scars and burns. Supplied pipeline information describes a locally applied formulation combining adipose-derived stem cells with hyaluronic acid, intended to promote tissue repair and reduce pathological scarring. A public AseBio entry identifies PRS SCARBOOST as an advanced cell-therapy candidate for surgical scars involving adult mesenchymal and fibroblast stem cells and fibroblast PRS; its intended biological activity is regenerative and immunomodulatory paracrine signaling rather than modulation of a disclosed molecular target. ([asebio.com](https://asebio.com/socios/directorio/peaches-biotech-sl/prs-scarboost))

Other names: PRS SCARBOOSTScar Boost

Beyond the preview

Go deeper on Scarboost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scarboost.

Explore the full profile